Now showing items 1-2 of 2

    • Novel oral anticoagulants in acute coronary syndrome 

      Costopoulos, C.; Niespialowska-Steuden, M.; Kukreja, N.; Gorog, Diana (2013-09-10)
      Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide with a prevalence that has now reached pandemic levels as a consequence of the rapid modernization of the developing world. Its presentation ...
    • PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease 

      Rosser, G.; Tricoci, P.; Morrow, D.; Christopoulos, C.; Niespialowska-Steuden, M.; Kozarski, Robert; Wilcox, R.; Gorog, Diana (2014-11)
      To assess the effect of vorapaxar on global thrombotic and thrombolytic status. The propensity for thrombus formation is determined by the balance between prothrombotic factors and endogenous thrombolysis. Impaired ...